Safety and Efficacy of a Monoclonal Antibody for Treatment of Rheumatoid Arthritis.

Authors
Category Primary study
Registry of TrialsClinicalTrials.gov
Year 2002
The purpose of this study is to determine whether a humanized monoclonal antibody (efalizumab) is safe and effective in the treatment of rheumatoid arthritis.
Epistemonikos ID: c8b544a1e98d36df3edbafbb4ff464e164ac4859
First added on: Mar 23, 2022